Cytotechnologists and on-site evaluation of adequacy

Jennifer A. Collins, Anna Novak, Syed Z. Ali, Matthew T. Olson

Research output: Contribution to journalReview articlepeer-review

Abstract

While fine needle aspiration (FNA) is certainly not a new biopsy technique, recent developments in advanced imaging techniques, molecular testing, and targeted therapies have coincided with a rapid increase in the number of FNA procedures being performed. Concurrently, the demand for on-site evaluation of adequacy (OSEA) has also increased, outstripping the capacity of available cytopathologists at some institutions. Among the several alternatives to cytopathologist-performed OSEA, cytotechnologist-attended OSEA stands out because it preserves the representation of the pathology service at the time of the procedure. Herein, we review the current literature about OSEA and the necessity of cytotechnologists to expand access of this useful pathology service to a broader patient population. We also examine how cytotechnologists are likely to fit into the emerging practice of telecytology.

Original languageEnglish (US)
Pages (from-to)405-410
Number of pages6
JournalKorean Journal of Pathology
Volume47
Issue number5
DOIs
StatePublished - Nov 19 2013

Keywords

  • Biopsy, fine needle aspiration
  • Cytotechnology
  • On-site evaluation of adequacy
  • Rapid on-site evaluation
  • Telecytology
  • Telepathology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Cytotechnologists and on-site evaluation of adequacy'. Together they form a unique fingerprint.

Cite this